Dr Gerbaudo is the Director of the Nuclear Medicine and Molecular Imaging Program, and the Associate Director of the Center for Pulmonary Functional Imaging, as well as the Senior Administrative Director of Noninvasive Cardiovascular Imaging in the Department of Radiology at the Brigham and Women’s Hospital, Harvard Medical School. He is a clinical Nuclear Oncology scientist with more than 20 years of experience in the field. His clinical, teaching and research efforts focus on the in-vivo qualitative and quantitative monitoring of tumor biology, imaging, and response to therapy with PET/CT. His teaching integrates the application of basic concepts of tumor pathophysiology and molecular pathology to oncologic imaging, and to the interpretation and integration of imaging results into management decisions. Topics of interest include molecular imaging of tumor cell proliferation, perfusion, apoptosis and glycolytic metabolism. His research focuses on the assessment and characterization of tumor invasion and metastasis with positron imaging of thoracic malignancies (i.e., malignant pleural mesothelioma, lung cancer), as well as esophageal cancer, brain and gastrointestinal tumors. His work in this area has expanded the use of clinical PET/CT for metabolically guided tumor biopsy and ablation, and for metabolic grading and staging of human tumors, as it relates to histological grade, molecular pathology, surgical stage and survival.